Main Finding(s): In a phase Ia clinical trial, immune cells called Tregs, which can inhibit anticancer immune responses, were efficiently eliminated from the blood of patients with lung or esophageal cancer by treatment with ...
Oct 1, 2015
0
10
Researchers at the University of Szeged in Hungary have demonstrated for the first time that an esophagus organoid successfully duplicates a vital function of that organ. The study is published in the American Journal of ...
Dec 2, 2021
0
21
Results of the NRG Oncology clinical trial RTOG 1010 indicate that the addition of the monoclonal antibody trastuzumab to neoadjuvant trimodality treatment did not improve disease-free survival (DFS) outcomes for patient ...
Jun 1, 2020
0
0
April is Esophageal Cancer Awareness Month, which makes this good time to learn the signs of esophageal cancer and what you can do to reduce your risk.
Apr 26, 2023
0
3
Female patients with locally advanced esophageal cancer that is treated with chemotherapy and radiation therapy before surgery are more likely to have a favorable response to the treatment than male patients are, and women ...
Aug 22, 2017
0
0
Irregularities in the body's genetic coding to make proteins are linked to cancerous tumors. But most genetic material contains elements whose function isn't clear.
May 15, 2023
0
14
Inflammation might be an important factor in the progression from reflux to esophageal cancer, according to a new study in Clinical Gastroenterology and Hepatology, the official journal of the American Gastroenterological ...
May 10, 2012
1
0
Barrett's esophagus (BE) develops in a subset of patients with gastroesophageal reflux disease (GERD) and can increase the risk of developing cancer of the esophagus. Although periodic surveillance for cancer is recommended ...
Jun 8, 2015
0
43
Esophageal cancer (EC) is one of the most common types of cancer worldwide and was ranked as the sixth leading cause of cancer-related deaths in 2020. When EC is localized or locally advanced, referred to as resectable EC, ...
Feb 1, 2023
0
7
A blood test may be beneficial in indicating neoadjuvant treatment regimens for patients with esophageal squamous cell carcinoma (ESCC), according to research presented today at the American Society for Radiation Oncology's ...
Sep 15, 2014
0
0
